Adults 45 and older should start routine colorectal cancer screenings. People at higher risk due to family history or other ...

Pfizer’s Talzenna in combi with Xtandi improves survival outcomes in metastatic castration resistant prostate cancer: New York Saturday, February 15, 2025, 11:00 Hrs [IST] Pfize ...

Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy ...

Increase in QOL and decrease in sexual function are among the benefits and risks, respectively, of adding SADT to EBRT for intermediate-risk prostate cancer.

SAN FRANCISCO -- Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when ...

Founding Duran Duran member and guitarist Andy Taylor’s battle with stage 4 prostate cancer is getting tougher, his bandmate revealed at a Thursday press conference according to the Daily Mail. Taylor ...

Members of Duran Duran offered an update on founding member and legendary guitarist Andy Taylor’s battle with stage-four ...

MyCareGorithm was met with high approval from patients, companions, and physicians, with all 3 groups reporting they’d ...

Updated data from the Phase III TALAPRO-2 trial show that the combination of Talzenna (talazoparib) and Xtandi (enzalutamide) significantly improves overall survival in patients with metastatic ...

The American Cancer Society's chief scientific officer outlines the group's research agenda, including a new project in ...

Positve overall survival data could lead to a label expansion for Pfizer's combination to treat metastatic ...

Combining talazoparib with enzalutamide significantly improves overall survival in patients with metastatic ...